振东制药
(300158)
| 流通市值：46.09亿 | | | 总市值：46.24亿 |
| 流通股本：10.24亿 | | | 总股本：10.27亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 652,192,702.52 | 800,880,110.6 | 974,682,707.26 | 885,235,637.16 |
| 应收票据及应收账款 | 713,668,237.36 | 752,047,063.52 | 778,480,043.66 | 795,014,217.89 |
| 其中：应收票据 | 68,398,976.32 | 127,119,264.74 | 132,583,041.68 | 157,128,014.19 |
| 应收账款 | 645,269,261.04 | 624,927,798.78 | 645,897,001.98 | 637,886,203.7 |
| 应收款项融资 | 87,214,524.39 | 103,995,257.18 | - | - |
| 预付款项 | 106,332,592.86 | 99,597,181.85 | 148,450,784.04 | 138,206,913.53 |
| 其他应收款合计 | 73,178,866.6 | 44,708,779.42 | 54,532,030.16 | 48,809,724.65 |
| 存货 | 1,130,531,304.43 | 1,195,450,192.1 | 1,214,275,309.91 | 1,134,495,091.75 |
| 其他流动资产 | 11,923,232.64 | 15,655,320.01 | 8,267,850.93 | 9,697,823.35 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 4,189,280,225.91 | 4,460,291,739.61 | 4,496,055,422.9 | 4,556,663,145.36 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 87,015,285.68 | 57,015,285.68 | 36,943,869.36 | 36,943,869.36 |
| 投资性房地产 | 14,866,864 | 15,650,347.87 | 15,851,854.5 | 16,053,361.12 |
| 固定资产 | 927,112,249.22 | 946,577,912.32 | 928,744,616.67 | 941,891,538.14 |
| 在建工程 | 54,126,423.32 | 44,977,242.41 | 47,437,701.22 | 35,837,040.4 |
| 生产性生物资产 | 987,232.35 | 987,232.35 | 1,069,501.71 | 1,069,501.71 |
| 使用权资产 | 2,513,073.86 | 2,356,223.61 | 2,596,040.03 | 2,835,856.44 |
| 无形资产 | 250,940,164.5 | 260,070,258.45 | 255,864,594.41 | 255,872,614.49 |
| 开发支出 | 194,451,488.27 | 194,429,571.95 | 200,825,198.94 | 198,197,723.14 |
| 商誉 | 40,239,614.18 | 40,239,614.18 | 40,239,614.18 | 40,239,614.18 |
| 长期待摊费用 | 5,480,153.82 | 5,945,340.37 | 5,222,827.69 | 6,841,955.83 |
| 递延所得税资产 | 21,159,106.37 | 21,009,297.19 | 19,810,530.35 | 19,987,051.16 |
| 其他非流动资产 | 196,316,008.98 | 130,946,969.32 | 90,083,068 | 88,566,540.73 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,795,207,664.55 | 1,720,205,295.7 | 1,644,689,417.06 | 1,644,336,666.7 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 5,984,487,890.46 | 6,180,497,035.31 | 6,140,744,839.96 | 6,200,999,812.06 |
| 流动负债: | | | | |
| 短期借款 | 97,801.11 | 97,801.11 | - | - |
| 应付票据及应付账款 | 336,893,292.29 | 417,995,887.04 | 450,754,472.14 | 491,075,655.69 |
| 其中：应付票据 | 40,945,501.12 | 37,981,226.65 | 36,522,463.38 | 37,741,033.66 |
| 应付账款 | 295,947,791.17 | 380,014,660.39 | 414,232,008.76 | 453,334,622.03 |
| 合同负债 | 80,027,088.56 | 68,424,414.32 | 61,921,937.46 | 86,760,752.84 |
| 应付职工薪酬 | 27,450,616.92 | 32,202,776.75 | 27,249,889.79 | 21,712,444.83 |
| 应交税费 | 30,683,721.97 | 22,746,446.27 | 37,435,853.45 | 45,905,593.2 |
| 其他应付款合计 | 271,884,136.93 | 285,534,465.35 | 242,734,786.28 | 215,289,789.38 |
| 一年内到期的非流动负债 | 1,230,787.26 | 1,224,153.26 | 806,573.39 | 806,573.39 |
| 其他流动负债 | 35,834,778.58 | 88,848,441.85 | 15,630,577.94 | 17,068,575.5 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 784,102,223.62 | 917,074,385.95 | 836,534,090.45 | 878,619,384.83 |
| 非流动负债: | | | | |
| 租赁负债 | 985,333.04 | 1,532,348.91 | 1,916,656.27 | 1,880,481.43 |
| 长期应付款 | 74,465,173.03 | 74,715,173.03 | 74,905,173.03 | 75,915,173.03 |
| 递延收益 | 42,407,871.95 | 42,769,835.99 | 39,575,033.66 | 40,420,402.19 |
| 递延所得税负债 | 296,836.88 | 296,836.88 | - | - |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 118,155,214.9 | 119,314,194.81 | 116,396,862.96 | 118,216,056.65 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 902,257,438.52 | 1,036,388,580.76 | 952,930,953.41 | 996,835,441.48 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,027,494,660 | 1,027,494,660 | 1,027,494,660 | 1,027,494,660 |
| 资本公积 | 3,762,314,237.72 | 3,762,314,237.72 | 3,762,314,237.72 | 3,762,314,237.72 |
| 减:库存股 | 84,225,122.53 | - | - | - |
| 其他综合收益 | -32,707,949.38 | -32,707,944.94 | -32,737,641.89 | -32,730,551.68 |
| 盈余公积 | 481,346,118.6 | 481,346,118.6 | 481,346,118.6 | 481,346,118.6 |
| 未分配利润 | -36,488,789.91 | -59,590,347.86 | -16,480,436.54 | -1,063,821.26 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,117,733,154.5 | 5,178,856,723.52 | 5,221,936,937.89 | 5,237,360,643.38 |
| 少数股东权益 | -35,502,702.56 | -34,748,268.97 | -34,123,051.34 | -33,196,272.8 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,082,230,451.94 | 5,144,108,454.55 | 5,187,813,886.55 | 5,204,164,370.58 |
| 负债和股东权益合计 | 5,984,487,890.46 | 6,180,497,035.31 | 6,140,744,839.96 | 6,200,999,812.06 |
| 公告日期 | 2024-04-23 | 2024-04-23 | 2023-10-23 | 2023-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |